Korean J Urol.  2010 Aug;51(8):561-564. 10.4111/kju.2010.51.8.561.

Is Activating Transcription Factor 3 Up-Regulated in Patients with Hypospadias?

• Gurbuz C
• Demir S
• Zemheri E
• Canat L
• Kilic M
• Caskurlu T

• KMID: 1997025
• DOI: http://doi.org/10.4111/kju.2010.51.8.561

Abstract

PURPOSE
Even though hypospadias is one of the most common congenital anomalies, the cause of hypospadias is largely unknown. With regard to molecular biology and microarray technology, it appears that hypospadias is potentially related to disrupted gene expression. Genomic analysis of hypospadiac tissue indicated a potential role for activating transcription factor 3 (ATF3) in the development of this anomaly. This study prospectively examined the expression of ATF3 in tissues from 20 children with hypospadias compared with 26 normal penile skin tissue samples from elective circumcision.
MATERIALS AND METHODS
Prepucial tissue was obtained from children who underwent repair of hypospadias for comparison with tissue samples from children who underwent elective circumcision. Skin specimens were evaluated for the expression of ATF3 protein by immunohistochemical staining.
RESULTS
Immunohistochemical staining for ATF3 in samples from children who underwent repair of hypospadias was significantly greater than in samples from children who underwent elective circumcision (80% vs. 11%, respectively; p<0.05).
CONCLUSIONS
Our results indicate that ATF3 is up-regulated in the penile skin tissue of boys with hypospadias, which suggests a role for this transcription factor in the development of this abnormality.

Keyword

Activating transcription factor 3; Estrogens; Genetics; Hypospadias; Urogenital abnormalities

MeSH Terms

Activating Transcription Factor 3
Child
Circumcision, Male
Estrogens
Female
Gene Expression
Humans
Hypospadias
Male
Molecular Biology
Prospective Studies
Skin
Transcription Factors
Urogenital Abnormalities
Activating Transcription Factor 3
Estrogens
Transcription Factors

Figure

• 

  FIG. 1 Activating transcription factor 3 (ATF3) immunoreactivity in hypospadic and control tissues (×100). (A) There is no ATF3 immunoreactivity in circumcision control tissue. (B) ATF3 is clearly expressed in the nucleous of the cell (arrow) in the sc tissue of subcoronal hypospadic sample. (C) ATF3 protein localized in the nuclei of stromal cells (black arrow) and the vascular endothelium (white arrow) in sc tissue of mid penil hypospadic sample.

Reference

1. Borer JG, Retik AB. Wein AJ, Kavuoussi LR, Novick AC, Partin AW, Peters CA, editors. Hypospadias. Campbell-Walsh urology. 2007. 9th ed. Philadelphia: Saunders;p. 2284–2327.

2. Paulozzi LJ, Erickson JD, Jackson RJ. Hypospadias trends in two US surveillance systems. Pediatrics. 1997; 100:831–834. PMID: 9346983.

3. Carmichael SL, Shaw GM, Nelson V, Selvin S, Torfs CP, Curry CJ. Hypospadias in California: trends and descriptive epidemiology. Epidemiology. 2003; 14:701–706. PMID: 14569186.

4. Steinhardt GF. Endocrine disruption and hypospadias. Adv Exp Med Biol. 2004; 545:203–215. PMID: 15086029.

5. Willingham E, Baskin LS. Candidate genes and their response to environmental agents in the etiology of hypospadias. Nat Clin Pract Urol. 2007; 4:270–279. PMID: 17483812.

6. Baskin LS. Hypospadias and urethral development. J Urol. 2000; 163:951–956. PMID: 10688029.

7. Yin X, Dewille JW, Hai T. A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development. Oncogene. 2008; 27:2118–2127. PMID: 17952119.

8. Thompson MR, Xu D, Williams BR. ATF3 transcription factor and its emerging roles in immunity and cancer. J Mol Med. 2009; 87:1053–1060. PMID: 19705082.

9. Kawauchi J, Zhang C, Nobori K, Hashimoto Y, Adachi MT, Noda A, et al. Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through down-regulation of p53 transcription. J Biol Chem. 2002; 277:39025–39034. PMID: 12161427.

10. Zhang C, Gao C, Kawauchi J, Hashimoto Y, Tsuchida N, Kitajima S. Transcriptional activation of the human stress-inducible transcriptional repressor ATF3 gene promoter by p53. Biochem Biophys Res Commun. 2002; 297:1302–1310. PMID: 12372430.

11. Nobori K, Ito H, Tamamori-Adachi M, Adachi S, Ono Y, Kawauchi J, et al. ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: a novel cardioprotective role of ATF3. J Mol Cell Cardiol. 2002; 34:1387–1397. PMID: 12392999.

12. Inoue A, Yoshida N, Omoto Y, Oguchi S, Yamori T, Kiyama R, et al. Development of cDNA microarray for expression profiling of estrogen-responsive genes. J Mol Endocrinol. 2002; 29:175–192. PMID: 12370120.

13. Duckett JW. Walsh PC, Retik AB, Vaughan ED, editors. Hypospadias. Campbell's urology. 1998. 7th ed. Philadelphia: Saunders;p. 2093–2119.

14. Utsch B, Albers N, Ludwig M. Genetic and molecular aspects of hypospadias. Eur J Pediatr Surg. 2004; 14:297–302. PMID: 15543478.

15. Liu B, Wang Z, Lin G, Agras K, Ebbers M, Willingham E, et al. Activating transcription factor 3 is up-regulated in patients with hypospadias. Pediatr Res. 2005; 58:1280–1283. PMID: 16306208.

16. Beleza-Meireles A, Töhönen V, Söderhäll C, Schwentner C, Radmayr C, Kockum I, et al. Activating transcription factor 3: a hormone responsive gene in the etiology of hypospadias. Eur J Endocrinol. 2008; 158:729–739. PMID: 18426833.

17. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med. 2002; 4:45–61. PMID: 11882781.

18. van der Zanden LF, van Rooij IA, Feitz WF, Vermeulen SH, Kiemeney LA, Knoers NV, et al. Genetics of hypospadias: are single-nucleotide polymorphisms in SRD5A2, ESR1, ESR2, and ATF3 really associated with the malformation? J Clin Endocrinol Metab. 2010; 95:2384–2390. PMID: 20215396.

19. Radpour R, Rezaee M, Tavasoly A, Solati S, Saleki A. Association of long polyglycine tracts (GGN repeats) in exon 1 of the androgen receptor gene with cryptorchidism and penile hypospadias in Iranian patients. J Androl. 2007; 28:164–169. PMID: 16957138.

20. Ban S, Sata F, Kurahashi N, Kasai S, Moriya K, Kakizaki H, et al. Genetic polymorphisms of ESR1 and ESR2 that may influence estrogen activity and the risk of hypospadias. Hum Reprod. 2008; 23:1466–1471. PMID: 18375409.